Compound ID | 940
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Gatifloxacin was developed as a broad spectrum antibiotic for a number of different infections including STIs, RTIs and eye disorders (3) |
| Description: | Hori S, Kanemitsu K, Shimada J. Inhibitory activity of AM-1155, a newly synthesized quinolone, on gamma aminobutyric acid receptor binding. 32nd-ICAAC 1992;277 |
| Institute where first reported: | Allergan, UK; Kyorin Pharmaceutical, Japan; Senju Pharmaceutical, Japan; AbbVie |
| Year first mentioned: | 1992 |
| Highest development stage: | Approved by FDA in 2010 |
| Development status: | Approved |
| Reason dropped: | Other formulations discontinued from market due to hypo- and hyper- glycaemia (2) |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5379 |
| Guide to Pharmacology: | gatifloxacin |
| Citations: |
|